Insulin resistance rarely appears as a single line labeled “Insulin Resistance.” It is inferred from multiple parameters. Lab reports typically list “Fasting Glucose,” “Fasting Insulin,” and “HbA1c.” Some systems calculate and display HOMA-IR directly; in other settings, it is calculated by the clinician. Additional markers such as triglycerides, HDL, liver enzymes (ALT/AST), and clinical metrics like waist circumference help complete the risk picture. If glucose looks normal while insulin is elevated, that can be consistent with early insulin resistance. The safest approach is to interpret results with internal medicine or endocrinology support, focusing not just on numbers but on comprehensive risk management.